BioSpace News Archive

Merix Pharmaceutical Corp., an industry leader in the treatment of cold sores and development of phyto-pharmaceutical technology, announces its proprietary botanical extract formula VIRACEA ® was found to be highly active against HSV-1 and HSV-2 in laboratory testing

Mike Robinson, a longtime executive at Aetna, former chair of the John Muir Health Board of Directors, and current Canopy Health Board Member, has been named chief executive officer (CEO) of Canopy Health.

Covalon Technologies Ltd. announced that it has appointed PricewaterhouseCoopers LLP (“Successor Auditor”) as its auditor.

Neurosurgeon Dr. Robert Masson Serves as the Principle Investigator Focused on Reinventing a 20-Year-Old Procedure

Arena Pharmaceuticals, Inc. announced the closing of the global license agreement with United Therapeutics Corporation for the Arena-discovered, Phase 3 investigational drug candidate ralinepag, a next-generation, oral, selective and potent prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension

Centerline Biomedical, Inc., announced on January 22nd that the company submitted a 510(k) premarket notification application to the United States Food and Drug Administration (FDA) for its flagship product, the Intra-Operative Positioning System, IOPS.

Increases Fourth Quarter Revenues 10% to $6.0 Billion, 9% for Full Year to $22.6 Billion

Exclusive license grants Vertex one clinical and one pre-clinical DNA-PK inhibitor for use in gene-editing applications in six specific genetic disease areas

New Insight from 9,000 AKI Patients Receiving Outpatient Dialysis Treatment; Large Collection of AKI Data is International First and Aims to Spur Further Investigation [24-January-2019] WALTHAM, Mass. , Jan. 24, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation’s leading renal care company, announces preliminary results from an analysis o

Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2018 financial results conference call and webcast for 8:00 a.m. ET on Thursday, February 14, 2019.